Krystal Biotech (KRYS) Other Working Capital Changes (2017 - 2026)
Krystal Biotech (KRYS) posted quarterly Other Working Capital Changes of $2.0 million for Q2 2026, up 168.83% year-over-year from $754000.0 in Q2 2025, and up 41.25% on a QoQ basis from $1.4 million in Q1 2026.
Krystal Biotech (KRYS) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Krystal Biotech has reported Other Working Capital Changes for 7 years, with the latest figure at $2.0 million in Q2 2026.
- Other Working Capital Changes for Q2 2026 came in at $2.0 million, up 168.83% year-over-year; the trailing twelve-month figure through Jun 2026 was $4.4 million (up 98.91% YoY), and the FY2025 annual result was $2.3 million, up 60.68% from the prior year.
- Other Working Capital Changes climbed to $2.0 million in Q2 2026, from $1.4 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $5.3 million in Q4 2024 and troughed at -$2.0 million in Q4 2025.
- A 5-year average of $760055.6 and a median of $202500.0 in 2024 frame the typical range for Other Working Capital Changes.
- The largest YoY upside for Other Working Capital Changes was 1585.71% in 2024 against a maximum downside of 23900.0% in 2024.
- A 5-year view of Other Working Capital Changes shows it stood at $258000.0 in 2022, then grew by 13.95% to $294000.0 in 2023, then surged by 123.81% to $658000.0 in 2024, then retreated by 14.59% to $562000.0 in 2025, then surged by 260.68% to $2.0 million in 2026.
- Per Business Quant data, the three most recent Other Working Capital Changes figures were $2.0 million in Q2 2026, $1.4 million in Q1 2026, and $562000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Krystal Biotech | 9.83 Bn | 8.99 Bn | 112.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 193,000.00 |
| Jun 30, 2026 | 193,000.00 |
| Jun 30, 2026 | 193,000.00 |
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Mar 31, 2026 | 1.70 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Dec 31, 2025 | -2.04 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Sep 30, 2025 | 1.35 Mn |
| Jun 30, 2025 | -476,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Jun 30, 2025 | -476,000.00 |
| Mar 31, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Mar 31, 2025 | 3.43 Mn |
| Dec 31, 2024 | 5.31 Mn |
| Dec 31, 2024 | 5.31 Mn |